How Assistance Works

Streamlining our patient’s specialty pharmacy experience with unmatched full-service convenience

  • Coverage Verification Code

    1. Check Your Coverage/Benefits Verification

    Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.

  • Transfer Prescription to AmeriPharma - Image

    2. Transfer Prescription to AmeriPharma®

    We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.

  • Icon - Eligard copay assistance process

    3. Prior Authorization

    Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.

  • Eligard Copay Financial Assistance Icon

    4. Copay Assistance & Financial Aid

    We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma® Specialty Care has secured $55 million in financial assistance for our patients.

  • Nursing Care Logo

    5. Nursing Care Coordination If Needed

    AmeriPharma® puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.

  • Delivery Coordination - Image

    6. Delivery Coordination

    Medications are always delivered in strict compliance with the specific requirements for shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.

What Is Cabenuva?

Cabenuva is a medicine that combines two different drugs, cabotegravir and rilpivirine, which are antiviral medications that target a virus known as human immunodeficiency virus type 1 (HIV-1). People infected with this virus are at risk of developing acquired immune deficiency (AIDS), a condition in which a person is unable to fight back against infections. The two HIV medicines, cabotegravir and rilpivirine, are slowly released into your body and keep the HIV level low enough that it won’t be detected using normal screening methods.

Where To Begin

It is important that you always consult your physician at any time before starting Cabenuva and especially during the course of the treatment. If you have been using any previous medication,  have not taken the necessary tests first, or have any other active illness, then your physician will first determine if the treatment is suitable for you or not. Your physician will guide and instruct you on the precautions, expectations, and appointment schedule.

It is also important that you show up for every appointment and do not miss any injections; otherwise, this may lead to treatment failure. Cabenuva is unique in that it has a flexible treatment window. Your injection can occur within 7 days before or 7 days after your designated appointment date. However, if you do miss out on a scheduled injection or intentionally want to discontinue treatment temporarily, you must contact your healthcare provider immediately to discuss further treatment options.

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/pharmacist.jpg
https://ameripharmaspecialty.com/wp-content/uploads/2024/02/block_image_1.jpg

What Should I Know About Being Treated With Cabenuva?

Cabenuva can be given to people aged 12 years or older with a weight of at least 35 kg. It is an intramuscular injectable drug that can only be administered by a healthcare provider. This injection is usually given in the muscles of the buttocks (gluteal region). There are two options for beginning Cabenuva. Your healthcare provider may start you on oral tablets for one month before switching to Cabenuva, or they may begin Cabenuva right away.

If started on the tablets, you will take two medications by mouth: Vocabria (cabotegravir) and Edurant (rilpivirine). These are the same two medications that make up Cabenuva. These two tablets will be swallowed daily, with a meal, for approximately 28 days. The last day of oral tablets will correspond with the first injection of Cabenuva.

If no oral tablets are used as a lead-in, Cabenuva will be given on the last day of your current antiviral therapy.

Cabenuva is injected in two parts, with one part containing cabotegravir and the other part containing rilpivirine. They will be administered in separate gluteal sites, at least two centimeters apart. It is common for injections to be given in opposite gluteal muscles (left and right). Cabenuva can be given once a month or once every 2 months. Your healthcare provider will help determine the best treatment schedule for you.

How Cabenuva Copay Assistance Works

AmeriPharma® Specialty Pharmacy alleviates financial burdens for patients and their families

  • Advanced software Icon

    Advanced software locates funding sources to match you with top-dollar foundation programs

  • Copay and Financial Assistance

    One of our copay assistance specialists will assist with the application process

  • Funding Icon

    Automatic updates will be sent to you and your physician on the status of the funding

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/Mask-Group-45-1.jpg

Drug Administration

Cabenuva can be given as an injectable either once monthly or every 2 months. Cabenuva comes in two injectable single dose kits: 600 mg cabotegravir/900 mg rilpivirine and 400 mg cabotegravir/600 mg rilpivirine.

The schedule for once monthly Cabenuva is given below:

  • Optional oral tablet lead-in: Tablets for cabotegravir (30 mg) and rilpivirine (25 mg), both taken daily with meals for at least 28 days.
  • 1st month: On the last day of taking the tablets, Cabenuva (600 mg cabotegravir/900 mg rilpivirine) is administered in the gluteal region, once.
  • 2nd month onwards: From the second month onwards, patients will receive Cabenuva (400 mg cabotegravir/600 mg rilpivirine) once monthly, in the glutes.

The schedule for bi-monthly Cabenuva is given below:

  • Optional oral tablet lead-in: Tablets for cabotegravir (30 mg) and rilpivirine (25 mg), both taken daily with meals for at least 28 days.
  • 1st month: On the last day of taking the tablets, Cabenuva (600 mg cabotegravir/900 mg rilpivirine) is administered in the gluteal region.
  • 2nd month: Cabenuva (600 mg cabotegravir/900 mg rilpivirine) is administered in the glutes.
  • 4th month onwards: Cabenuva (600 mg cabotegravir/900 mg rilpivirine) is administered in the gluteal region every 2 months.

Cabenuva Side Effects

Common side effects include:
  • Pain
  • Tenderness
  • Swelling
  • Redness
  • Itching
  • Nausea
  • Fever
  • Rash
  • Headache
  • Lethargy (tiredness)
  • Body aches
  • Insomnia (difficulty sleeping)
  • Dizziness

 

Severe side effects include:
  • Dyspnea (difficulty breathing)
  • Wheezing
  • Blisters or sores on the body
  • Redness of the eyes
  • Swelling of any part of the face, lips, or tongue
  • Jaundice (yellowing of the skin or eyes)
  • Dark-colored urine
  • Light-colored stool
  • Loss of appetite
  • Abdominal pain
  • Generalized nausea

Insurances Accepted

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

  • Medicare logo displayed in the website footer.
  • Medicaid logo
  • Blue Cross Blue Shield Logo

Get Started in Minutes

Fill out your information and one of our specialists will call you ASAP.

How Much Can You Save?

Complete this form to save up to 100%!

HIPAA Compliant